Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: A randomized, placebo controlled trial for dose optimization in 128 healthy subjects
Titel:
Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: A randomized, placebo controlled trial for dose optimization in 128 healthy subjects
Auteur:
Firbas, Christa Jilma, Bernd Tauber, Erich Buerger, Vera Jelovcan, Sandra Lingnau, Karen Buschle, Michael Frisch, Jürgen Klade, Christoph S.